Home › NDC Lookup › Ingredients › Camphor › 87731-0001-01
CHEONG KUN PAIN RELIEVING CAMPHOR .2 g/100mL Oil, 38 mL — NDC 87731-0001-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

CHEONG KUN PAIN RELIEVING CAMPHOR .2 g/100mL Oil, 38 mL — NDC 87731-001-01 (Billing 87731-0001-01)

by CHEONG KUN PAIN RELIEVER OIL CHINESE MEDICINE FACTORY (MACAU) LIMITED · 38 mL in 1 BOTTLE, PLASTIC

This is a package of 38 mL of CHEONG KUN PAIN RELIEVING CAMPHOR .2 g/100mL Oil from CHEONG KUN PAIN RELIEVER OIL CHINESE MEDICINE FACTORY (MACAU) LIMITED, marketed since Aug 2026 and currently FDA-listed. It is this product's only package size.

NDC 87731-0001-01
🏷️ FDA NDC (as labeled) 87731-001-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Aug 20, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 87731-001-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
87731 labeler · 001 product · 01 package
Package marketed since
Aug 1, 2026
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 8773100101 9
FDA record last changed
Aug 20, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 87731-001-01
Product NDC 87731-001
11-digit billing NDC 87731000101
RxCUI 2748479
UNII 5TJD82A1ET
Application # M017
SPL Set ID 557d5cb3-2a05-4f45-e063-6394a90a9b12
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-08-01
Route TOPICAL
Dosage form OIL
Substance CAMPHOR (SYNTHETIC)
Quick answers
  • RxCUI (RxNorm): 2748479
Why two NDCs? The FDA registers this code as 87731-001-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 87731-0001-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

Cheong Kun Pain Relieving Camphor Oil is a topical oil product containing synthetic camphor. Camphor is commonly used in over-the-counter pain-relief products applied to the skin, where it typically produces a warming or cooling sensation. This product is marketed as an OTC monograph drug, meaning it follows FDA's established rules for this category of topical pain-relief products rather than undergoing individual review.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
87731-0001-01 You're viewing this Main listing 38 mL in 1 BOTTLE, PLASTIC 2026-08-01 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Cheong Kun Pain Relieving .2 g/100mLthis 87731-0001-01 CHEONG 38 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
Aug 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII B7ZE99AJ7D
    A plant extract from the flowering quince fruit. In medicines, it may serve as a flavoring agent, colorant, or natural ingredient to improve taste and appearance.
  • UNII LB1GQP4253
    A plant extract from the teasel root used as a traditional herbal ingredient. In medicines, it may function as a filler or binder to help hold the product together and maintain its form.
  • UNII M3YJ2C28IC
    Dragon's blood is a natural red resin obtained from tropical plants. It's used in medicines as a colorant and binding agent to give pills and capsules their appearance and help hold ingredients together.
  • UNII 731W842X8Q
    A plant extract from the Drynaria fortunei fern root, traditionally used in herbal medicine. In formulations, it may serve as an active botanical ingredient or functional additive, though its specific role depends on the product type.
  • UNII R9XLF1R1WM
    Frankincense is a natural resin from the Boswellia tree. It's used in medicines as a binder or thickener to help hold ingredients together and improve the product's consistency and texture.
  • UNII N6K5787QVP
    Light mineral oil is a clear, odorless liquid derived from petroleum. In medicines, it acts as a lubricant and emollient to help the product spread smoothly and improve texture.
  • UNII T3122X64V3
    A plant material derived from a specific variety of Lycopus (water horehound) flowering tops, used as a natural flavoring or fragrance agent and potentially as a traditional botanical extract in the formulation.
  • UNII JC71GJ1F3L
    Myrrh is a natural resin obtained from a tree, traditionally used in medicines and perfumes. It may serve as a flavoring agent, fragrance, or mild preservative in formulations.
  • UNII V9C81470RR
    A plant-derived ingredient from peach seeds used as a natural emollient and skin-conditioning agent in topical formulations. It helps soften and smooth the product's texture.
  • UNII G025DAL7CE
    A plant extract from rhubarb root used as a natural colorant and flavoring agent in medicines. It may also help stimulate bowel movement in laxative formulations.
  • UNII 4VBL71TY4Y
    Safflower is a plant-derived ingredient used as a natural colorant and flavoring agent in medicines. It may also serve as a filler to add bulk to the formulation.

11 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesChaenomeles Speciosa, Dipsacus Asper Root, Dragon’s Blood, Drynaria Fortunei Root, Frankincense, Light Mineral Oil, Lycopus Lucidus Var. Hirtus Flowering Top, Myrrh, Prunus Persica Seed, Rheum Palmatum Root, Safflower

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCHEONG KUN PAIN RELIEVER OIL CHINESE MEDICINE FACTORY (MACAU) LIMITED
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code87731
First marketedAug 2026
Product typeHuman Otc Drug
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 26 words ▾

Uses For the temporary relief of pain associated with: ■ minor burns ■ minor cuts ■ insect bites ■ sunburn ■ scrapes ■ minor skin irritation

⏱️ Dosage and Administration 36 words ▾

Directions ■ adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily. ■ children under 2 years of age: Do not use, consult a doctor.

⚠️ Warnings 5 words ▾

Warnings For external use only

📦 Storage and Handling 15 words ▾

Other information ■ protect from excessive heat, light and moisture ■ keep container tightly closed

🧪 Active Ingredient 4 words ▾

Active ingredients Camphor 0.2%

🧪 Inactive Ingredients 30 words ▾

Inactive ingredients Chaenomeles Speciosa, Dipsacus Asper Root, Dragon’s Blood, Drynaria Fortunei Root, Frankincense, Light Mineral Oil, Lycopus Lucidus Var. Hirtus Flowering Top, Myrrh, Prunus Persica Seed, Rheum Palmatum Root, Safflower

🎯 Purpose 3 words ▾

Purpose External analgesic

📄 When Using This Product 10 words ▾

When using this product ■ avoid contact with the eyes

📄 Stop Use and Ask a Doctor If 29 words ▾

Stop use and ask a doctor if ■ condition worsens ■ symptoms persist for more than 7 days ■ symptoms clear up and occur agin within a few days

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 13 words ▾

Questions or comments? (888) 221-3496 M-F 9 am to 5 pm Pacific Time.

📄 Package Label / Principal Display Panel 16 words ▾

CHEONG KUN PAIN RELIEVING OIL NDC 87731-001-01 EXTERNAL ANALGESIC

1.28FL. OZ. (38ML) IMAGE OF CARTON

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for CHEONG KUN PAIN RELIEVING (this brand).

Top reported reactions

Fatigue30
Drug Hypersensitivity29
Pain29
Pruritus26
Headache24
Pneumonia24
Dyspnoea23

Age at onset

Neonate1
Infant1
Adolescent1
Adult19
Elderly16

Reporter sex

167 reports
Male · 39%
Female · 61%

Serious outcomes

Death14
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 32 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by CHEONG KUN PAIN RELIEVER OIL CHINESE MEDICINE FACTORY (MACAU) LIMITED. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
CHEONG KUN PAIN RELIEVER OIL CHINESE MEDICINE FACTORY (MACAU) LIMITED is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 87730-0004-01 · Zhuhai 87735-0003-01 · Sephoris →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.